Conavi Medical (CNVI) Stock Price, News & Analysis

Company Overview

Conavi Medical is a Canadian medical technology company that develops advanced diagnostic tools for interventional cardiology. Its flagship offering is the Coroventis Coro360° System, a catheter-based platform that employs convective heat-transfer sensors to provide real-time quantitative measurements of absolute coronary blood flow and microvascular resistance. By delivering physiologic data at the point of care, Conavi’s system aims to enhance decision-making during coronary interventions and improve patient outcomes.

The Coro360° System integrates seamlessly with existing cath lab workflows, allowing clinicians to assess both epicardial and microvascular function without reliance on pharmacologic hyperemia. This approach can reduce procedural time and mitigate patient discomfort. Conavi continues to refine its technology through ongoing clinical collaborations and bench research, with a focus on expanding indications and demonstrating long-term clinical utility.

Founded in 2015 and headquartered in Calgary, Alberta, Conavi Medical launched its initial public listing on the TSX Venture Exchange in 2018. The company’s operations primarily serve interventional cardiology centers across North America and Europe. Conavi’s leadership team comprises seasoned medical device and cardiology professionals dedicated to advancing the standard of care in coronary physiology assessment.

Key Stats

• Today's Range: C$0.29 to C$0.30
• 50-Day Range: C$0.28 to C$0.48
• 52-Week Range: C$0.28 to C$0.70
• Volume: 3,648 shs
• Average Volume: 60,788 shs
• Market Capitalization: C$30.01 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Strong Buy

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: CVE:CNVI
• Previous Symbol: CVE:CNV
• CIK: N/A
• Web: www.conavimedical.com
• Phone: +1-604-408-7497
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: C$706 thousand
• Price / Sales: 42.51
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 103,492,000
• Free Float: N/A
• Market Cap: C$30.01 million
• Optionable: N/A
• Beta: N/A